Early Access

Executive Summary

Italy has a notoriously lengthy market access process, however several Early Access schemes enable physicians to apply for promising innovative treatments that have already been approved in other countries, where there are no valid therapeutic alternatives on the domestic market. This section breaks down the remits and criteria of the different schemes, and contains practical information for those considering applications.